Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: A biochemical, behavioral, and histological study

Background and Purpose: Following traumatic brain injury, inflammation, mitochondrial dysfunction, oxidative stress, ischemia, and energy crisis can cause mortality or long-term morbidity. As an activator of AMP-activated protein kinase, metformin reduces the secondary injuries of traumatic brain injury by compensating for the lack of energy in damaged cells. But the blood-brain barrier prevents a hydrophilic drug such as metformin from penetrating the brain tissue. Solid lipid nanoparticles with their lipid nature can cross the blood-brain barrier and solve this challenge. so This study aimed to investigate the effect of metformin-loaded lipid nanoparticles (NanoMet) for drug delivery to the brain and reduce complications from traumatic brain injury.Method: Different formulations of NanoMet were designed by Box-Behnken, and after formulation, particle size, zeta potential, and entrapment efficiency were investigated. For in vivo study, Male rats were divided into eight groups, and except for the intact and sham groups, the other groups underwent brain trauma by the Marmarou method. After the intervention, the Veterinary Coma Scale, Vestibular Motor function, blood-brain barrier integrity, cerebral edema, level of inflammatory cytokines, and histopathology of brain tissue were assessed.Results: The optimal formula had a size of 282.2 +/- 9.05 nm, a zeta potential of-1.65 +/- 0.33 mV, and entrapment efficiency of 60.61 +/- 6.09% which released the drug in 1400 min. Concentrations of 5 and 10 mg/kg of this formula improved the consequences of trauma. Conclusion: This study showed that nanoparticles could help target drug delivery to the brain and apply the desired result.

Automated summary

This study investigates the use of metformin-loaded lipid nanoparticles (NanoMet) for targeted drug delivery to the brain and reduction of complications from traumatic brain injury. The optimal formulation of these nanoparticles demonstrated suitable particle size, entrapment efficiency, and drug release. Administration of this formulation at specific concentrations improved the outcomes of brain trauma, indicating the potential of nanoparticles for desired drug delivery to the brain.